Clinical, endocrine, and metabolic effects of two doses of gestrinone in treatment of pelvic endometriosis
- 28 February 1997
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 176 (2) , 387-394
- https://doi.org/10.1016/s0002-9378(97)70504-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Gestrinone versus danazol in the treatment of endometriosisPublished by Elsevier ,2016
- A randomized double-blind prospective trial of two doses of gestrinone in the treatment of endometriosisFertility and Sterility, 1990
- Endocrine, metabolic, and clinical effects of gestrinone in women with endometriosisFertility and Sterility, 1989
- The morphologic effect of short-term medical therapy of endometriosisAmerican Journal of Obstetrics and Gynecology, 1987
- Impact of gestrinone on the course of asymptomatic endometriosis.BMJ, 1987
- Human ovarian oxytocin: Its source and relationship to steroid hormonesAmerican Journal of Obstetrics and Gynecology, 1986
- Revised American Fertility Society Classification of Endometriosis: 1985Fertility and Sterility, 1985
- The Effect of Naloxone on Endogenous Opioid Regulation of Pituitary Gonadotropins and Prolactin during the Menstrual Cycle*Journal of Clinical Endocrinology & Metabolism, 1984
- Treatment of endometriosis with gestrinone (R-2323), a synthetic antiestrogen, antiprogesteroneAmerican Journal of Obstetrics and Gynecology, 1982
- A new approach to estrogen-free contraception based on progesterone receptor blockage by mid-cycle administration of ethyl norgestrienone (R 2323)Contraception, 1974